Evidence map›Paper›PMID 21239516›Full record

ArticleThe Journal of clinical endocrinology and metabolism2011

Sterol O-acyltransferase 1 (SOAT1, ACAT) is a novel target of steroidogenic factor-1 (SF-1, NR5A1, Ad4BP) in the human adrenal.

Bruno Ferraz-de-Souza, Rebecca E Hudson-Davies, Lin Lin, Rahul Parnaik, Mike Hubank, Mehul T Dattani, John C Achermann

Open access · hybridAbstract readValidation Study
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Lipid metabolism in the adrenal gland.Frontiers in endocrinology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.International journal of molecular sciences · 2018
    Review
  12. Article
  13. POD-1/Tcf21 overexpression reduces endogenous SF-1 and StAR expression in rat adrenal cells.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2015
    Article
  14. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease.Best practice & research. Clinical endocrinology & metabolism · 2015
    Review
  15. Review
  16. Review
  17. Article
  18. Steroidogenic factor-1 and human disease.Seminars in reproductive medicine · 2012
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bruno Ferraz-de-SouzaUniversity College London Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom.
Rebecca E Hudson-Davies
Lin Lin
Rahul Parnaik
Mike Hubank
Mehul T Dattani
John C Achermann
University College London · GB

Funding

Medical Research Council G0700089Medical Research Council G9900837Wellcome Trust 079666Wellcome Trust GR079666Wellcome Trust GR082557
6 · The paper itself

Abstract

contextSteroidogenic factor-1 (SF-1, NR5A1, Ad4BP) is a master regulator of adrenal development and steroidogenesis. Defects in several known targets of SF-1 can cause adrenal disorders in humans.

objectiveWe aimed to identify novel targets of SF-1 in the human adrenal. These factors could be important regulators of adrenal development and steroidogenesis and potential candidates for adrenal dysfunction.

designA gene discovery strategy was developed based on bidirectional manipulation of SF-1. Overexpression or knockdown of SF-1 in NCI-H295R human adrenocortical cells was used to identify a subset of positively-regulated SF-1 targets.

resultsThis approach identified well-established SF-1 target genes (STAR, CYP11A) and several novel genes (VSNL1, ZIM2, PEG3, SOAT1, and MTSS1). Given its role in cholesterol metabolism, sterol O-acyltransferase 1 (SOAT1, previously referred to as acyl-Coenzyme A:cholesterol acyltransferase 1, ACAT) was studied further and found to be expressed in the developing human fetal adrenal cortex. We hypothesized that impaired SOAT1 activity could result in adrenal insufficiency through reduced cholesteryl ester reserves or through toxic destruction of the adrenal cells during development. Therefore, mutational analysis of SOAT1 in a cohort of 43 patients with unexplained adrenal insufficiency was performed but failed to reveal significant coding sequence changes.

conclusionsOur reverse discovery approach led to the identification of novel SF-1 targets and defined SOAT1 as an important factor in human adrenal steroidogenesis. SF-1-dependent up-regulation of SOAT1 may be important for maintaining readily-releasable cholesterol reserves needed for active steroidogenesis and during episodes of recurrent stress.

Indexed as

Gene Expression Regulation, EnzymologicAdrenal GlandsCells, CulturedCholesterolCluster AnalysisEmbryo, MammalianGene Expression ProfilingGene Expression Regulation, DevelopmentalHumansMicroarray AnalysisModels, BiologicalRNA, Small InterferingSteroidogenic Factor 1SteroidsSterol O-AcyltransferaseStress, PhysiologicalCholesterolNR5A1 protein, humanRNA, Small InterferingSteroidogenic Factor 1SteroidsSterol O-Acyltransferasesterol O-acyltransferase 1

Identifiers

PMID21239516
PMCPMC3124353
OpenAlexW2126802120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.